Eisai
4523.T
#1544
Rank
โ‚ฌ10.31 B
Marketcap
36,46ย โ‚ฌ
Share price
2.29%
Change (1 day)
-35.65%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): โ‚ฌ0.40 B

According to Eisai's latest financial reports the company's current earnings (TTM) are โ‚ฌ0.39 B. In 2023 the company made an earning of โ‚ฌ0.47 B an increase over its 2022 earnings that were of -โ‚ฌ20.63 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ0.40 B-14.79%
2023 โ‚ฌ0.47 B-2392.87%
2022 -โ‚ฌ20.63 M-103.6%
2021 โ‚ฌ0.57 B-39.52%
2020 โ‚ฌ0.94 B7.3%
2019 โ‚ฌ0.88 B17.23%
2018 โ‚ฌ0.75 B86.06%
2017 โ‚ฌ0.40 B-23.64%
2016 โ‚ฌ0.53 B27.28%
2015 โ‚ฌ0.41 B22.08%
2014 โ‚ฌ0.34 B-46.11%
2013 โ‚ฌ0.63 B-21.67%
2012 โ‚ฌ0.80 B-20.72%
2011 โ‚ฌ1.01 B-8.44%
2010 โ‚ฌ1.11 B18.85%
2009 โ‚ฌ0.93 B